Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.
Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.
复制标题
DOI:
10.1084/jem.20130762
复制
发表时间:
2013-10-21
期刊:
影响因子:
--
通讯作者:
Rudensky AY
中科院分区:
文献类型:
--
作者:
Bos PD;Plitas G;Rudra D;Lee SY;Rudensky AY
Transient ablation of regulatory T cells in a murine model of breast carcinogenesis inhibits primary tumor and lung metastatic growth and enhances the therapeutic effect of radiotherapy, but not immune checkpoint blockade. Rational combinatorial therapeutic strategies have proven beneficial for the management of cancer. Recent success of checkpoint blockade in highly immunogenic tumors has renewed interest in immunotherapy. Regulatory T (T reg) cells densely populate solid tumors, which may promote progression through suppressing anti-tumor immune responses. We investigated the role of T reg cells in murine mammary carcinogenesis using an orthotopic, polyoma middle-T antigen-driven model in Foxp3DTR knockin mice. T reg cell ablation resulted in significant determent of primary and metastatic tumor progression. Importantly, short-term ablation of T reg cells in advanced spontaneous tumors led to extensive apoptotic tumor cell death. This anti-tumor activity was dependent on IFN-γ and CD4+ T cells but not on NK or CD8+ T cells. Combination of T reg cell ablation with CTLA-4 or PD-1/PD-L1 blockade did not affect tumor growth or improve the therapeutic effect attained by T reg cell ablation alone. However, T reg cell targeting jointly with tumor irradiation significantly reduced tumor burden and improved overall survival. Together, our results demonstrate a major tumor-promoting role of T reg cells in an autochthonous model of tumorigenesis, and they reveal the potential therapeutic value of combining transient T reg cell ablation with radiotherapy for the management of poorly immunogenic, aggressive malignancies.
登录
查看更多内容
DOI:
10.1056/nejmoa1003466
发表时间:
2010-08-19
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hodi FS;O'Day SJ;McDermott DF;Weber RW;Sosman JA;Haanen JB;Gonzalez R;Robert C;Schadendorf D;Hassel JC;Akerley W;van den Eertwegh AJ;Lutzky J;Lorigan P;Vaubel JM;Linette GP;Hogg D;Ottensmeier CH;Lebbé C;Peschel C;Quirt I;Clark JI;Wolchok JD;Weber JS;Tian J;Yellin MJ;Nichol GM;Hoos A;Urba WJ
通讯作者:
Urba WJ
DOI:
10.1038/nri3405
发表时间:
2013-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1084/jem.20122462
发表时间:
2013-06-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Gasteiger G;Hemmers S;Firth MA;Le Floc'h A;Huse M;Sun JC;Rudensky AY
通讯作者:
Rudensky AY
DOI:
10.1038/nrc3239
发表时间:
2012-03-22
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
Pardoll DM
通讯作者:
Pardoll DM
DOI:
10.1056/nejmoa1200694
发表时间:
2012-06-28
期刊:
The New England journal of medicine
影响因子:
--
作者:
Brahmer JR;Tykodi SS;Chow LQ;Hwu WJ;Topalian SL;Hwu P;Drake CG;Camacho LH;Kauh J;Odunsi K;Pitot HC;Hamid O;Bhatia S;Martins R;Eaton K;Chen S;Salay TM;Alaparthy S;Grosso JF;Korman AJ;Parker SM;Agrawal S;Goldberg SM;Pardoll DM;Gupta A;Wigginton JM
通讯作者:
Wigginton JM